More Like this

1. Identification of condition-specific regulatory mechanisms in normal and cancerous human lung tissue

   https://doi.org/10.1186/s12864-022-08591-9  

   Hang, Yuqing; Burns, Josh; Shealy, Benjamin T.; Pauly, Rini; Ficklin, Stephen P.; Feltus, Frank A. (December 2022, BMC Genomics)

   Abstract Background Lung cancer is the leading cause of cancer death in both men and women. The most common lung cancer subtype is non-small cell lung carcinoma (NSCLC) comprising about 85% of all cases. NSCLC can be further divided into three subtypes: adenocarcinoma (LUAD), squamous cell carcinoma (LUSC), and large cell lung carcinoma. Specific genetic mutations and epigenetic aberrations play an important role in the developmental transition to a specific tumor subtype. The elucidation of normal lung versus lung tumor gene expression patterns and regulatory targets yields biomarker systems that discriminate lung phenotypes (i.e., biomarkers) and provide a foundation for the discovery of normal and aberrant gene regulatory mechanisms. Results We built condition-specific gene co-expression networks (csGCNs) for normal lung, LUAD, and LUSC conditions. Then, we integrated normal lung tissue-specific gene regulatory networks (tsGRNs) to elucidate control-target biomarker systems for normal and cancerous lung tissue. We characterized co-expressed gene edges, possibly under common regulatory control, for relevance in lung cancer. Conclusions Our approach demonstrates the ability to elucidate csGCN:tsGRN merged biomarker systems based on gene expression correlation and regulation. The biomarker systems we describe can be used to classify and further describe lung specimens. Our approach is generalizable and can be used to discover and interpret complex gene expression patterns for any condition or species. 

   more » « less
2. Composition and Functional Potential of the Human Mammary Microbiota Prior to and Following Breast Tumor Diagnosis

   https://doi.org/10.1128/msystems.01489-21  

   Hoskinson, Courtney; Zheng, Kelly; Gabel, Jaelyn; Kump, Annie; German, Rana; Podicheti, Ram; Marino, Natascia; Stiemsma, Leah T. (June 2022, mSystems)

   Gibbons, Sean M. (Ed.)

   ABSTRACT Microbiota studies have reported changes in the microbial composition of the breast upon cancer development. However, results are inconsistent and limited to the later phases of cancer development (after diagnosis). We analyzed and compared the resident bacterial taxa of histologically normal breast tissue (healthy, H, n  = 49) with those of tissues donated prior to (prediagnostic, PD, n  = 15) and after (adjacent normal, AN, n  = 49, and tumor, T, n  = 46) breast cancer diagnosis ( n total = 159). DNA was isolated from tissue samples and submitted for Illumina MiSeq paired-end sequencing of the V3-V4 region of the 16S gene. To infer bacterial function in breast cancer, we predicted the functional bacteriome from the 16S sequencing data using PICRUSt2. Bacterial compositional analysis revealed an intermediary taxonomic signature in the PD tissue relative to that of the H tissue, represented by shifts in Bacillaceae , Burkholderiaceae , Corynebacteriaceae , Streptococcaceae , and Staphylococcaceae . This compositional signature was enhanced in the AN and T tissues. We also identified significant metabolic reprogramming of the microbiota of the PD, AN, and T tissue compared with the H tissue. Further, preliminary correlation analysis between host transcriptome profiling and microbial taxa and genes in H and PD tissues identified altered associations between the human host and mammary microbiota in PD tissue compared with H tissue. These findings suggest that compositional shifts in bacterial abundance and metabolic reprogramming of the breast tissue microbiota are early events in breast cancer development that are potentially linked with cancer susceptibility. IMPORTANCE The goal of this study was to determine the role of resident breast tissue bacteria in breast cancer development. We analyzed breast tissue bacteria in healthy breast tissue and breast tissue donated prior to (precancerous) and after (postcancerous) breast cancer diagnosis. Compared to healthy tissue, the precancerous and postcancerous breast tissues demonstrated differences in the amounts of breast tissue bacteria. In addition, breast tissue bacteria exhibit different functions in pre-cancerous and post-cancerous breast tissues relative to healthy tissue. These differences in function are further emphasized by altered associations of the breast tissue bacteria with gene expression in the human host prior to cancer development. Collectively, these analyses identified shifts in bacterial abundance and metabolic function (dysbiosis) prior to breast tumor diagnosis. This dysbiosis may serve as a therapeutic target in breast cancer prevention. 

   more » « less
3. Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer

   https://doi.org/10.3390/ijms241310561  

   Ye, Qing; Wang, Jiajia; Ducatman, Barbara; Raese, Rebecca A.; Rogers, Jillian L.; Wan, Ying-Wooi; Dong, Chunlin; Padden, Lindsay; Pugacheva, Elena N.; Qian, Yong; et al (July 2023, International Journal of Molecular Sciences)

   There is currently no gene expression assay that can assess if premalignant lesions will develop into invasive breast cancer. This study sought to identify biomarkers for selecting patients with a high potential for developing invasive carcinoma in the breast with normal histology, benign lesions, or premalignant lesions. A set of 26-gene mRNA expression profiles were used to identify invasive ductal carcinomas from histologically normal tissue and benign lesions and to select those with a higher potential for future cancer development (ADHC) in the breast associated with atypical ductal hyperplasia (ADH). The expression-defined model achieved an overall accuracy of 94.05% (AUC = 0.96) in classifying invasive ductal carcinomas from histologically normal tissue and benign lesions (n = 185). This gene signature classified cancer development in ADH tissues with an overall accuracy of 100% (n = 8). The mRNA expression patterns of these 26 genes were validated using RT-PCR analyses of independent tissue samples (n = 77) and blood samples (n = 48). The protein expression of PBX2 and RAD52 assessed with immunohistochemistry were prognostic of breast cancer survival outcomes. This signature provided significant prognostic stratification in The Cancer Genome Atlas breast cancer patients (n = 1100), as well as basal-like and luminal A subtypes, and was associated with distinct immune infiltration and activities. The mRNA and protein expression of the 26 genes was associated with sensitivity or resistance to 18 NCCN-recommended drugs for treating breast cancer. Eleven genes had significant proliferative potential in CRISPR-Cas9/RNAi screening. Based on this gene expression signature, the VEGFR inhibitor ZM-306416 was discovered as a new drug for treating breast cancer. 

   more » « less
4. Characterization of Expression-Based Gene Clusters Gives Insights into Variation in Patient Response to Cancer Therapies

   https://doi.org/10.1177/11769351241271560  

   Neary, Bridget; Qiu, Peng (September 2024, Cancer Informatics)

   Background:Transcriptomics can reveal much about cellular activity, and cancer transcriptomics have been useful in investigating tumor cell behaviors. Patterns in transcriptome-wide gene expression can be used to investigate biological mechanisms and pathways that can explain the variability in patient response to cancer therapies. Methods:We identified gene expression patterns related to patient drug response by clustering tumor gene expression data and selecting from the resulting gene clusters those where expression of cluster genes was related to patient survival on specific drugs. We then investigated these gene clusters for biological meaning using several approaches, including identifying common genomic locations and transcription factors whose targets were enriched in these clusters and performing survival analyses to support these candidate transcription factor-drug relationships. Results:We identified gene clusters related to drug-specific survival, and through these, we were able to associate observed variations in patient drug response to specific known biological phenomena. Specifically, our analysis implicated 2 stem cell-related transcription factors, HOXB4 and SALL4, in poor response to temozolomide in brain cancers. In addition, expression of SNRNP70 and its targets were implicated in cetuximab response by 3 different analyses, although the mechanism remains unclear. We also found evidence that 2 cancer-related chromosomal structural changes may impact drug efficacy. Conclusion:In this study, we present the gene clusters identified and the results of our systematic analysis linking drug efficacy to specific transcription factors, which are rich sources of potential mechanistic relationships impacting patient outcomes. We also highlight the most promising of these results, which were supported by multiple analyses and by previous research. We report these findings as promising avenues for independent validation and further research into cancer treatments and patient response. 

   more » « less
5. EdgeCrafting: mining embedded, latent, nonlinear patterns to construct gene relationship networks

   https://doi.org/10.1093/g3journal/jkac042  

   Husain, Benafsh; Reed Bender, Matthew; Alex Feltus, Frank (February 2022, G3 Genes|Genomes|Genetics)

   Cherry, J M (Ed.)

   Abstract The mechanisms that coordinate cellular gene expression are highly complex and intricately interconnected. Thus, it is necessary to move beyond a fully reductionist approach to understanding genetic information flow and begin focusing on the networked connections between genes that organize cellular function. Continued advancements in computational hardware, coupled with the development of gene correlation network algorithms, provide the capacity to study networked interactions between genes rather than their isolated functions. For example, gene coexpression networks are used to construct gene relationship networks using linear metrics such as Spearman or Pearson correlation. Recently, there have been tools designed to deepen these analyses by differentiating between intrinsic vs extrinsic noise within gene expression values, identifying different modules based on tissue phenotype, and capturing potential nonlinear relationships. In this report, we introduce an algorithm with a novel application of image-based segmentation modalities utilizing blob detection techniques applied for detecting bigenic edges in a gene expression matrix. We applied this algorithm called EdgeCrafting to a bulk RNA-sequencing gene expression matrix comprised of a healthy kidney and cancerous kidney data. We then compared EdgeCrafting against 4 other RNA expression analysis techniques: Weighted Gene Correlation Network Analysis, Knowledge Independent Network Construction, NetExtractor, and Differential gene expression analysis. 

   more » « less